Pinnacle Wealth Planning Services’s Avidity Biosciences RNAM Stock Holding History
Bought
Maintained
Sold
Other funds holding RNAM
Pinnacle Wealth Planning Services's RNAM Position: Q1 2026 in Review
Pinnacle Wealth Planning Services sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 297 shares — an estimated $21.4K sold.
Pinnacle Wealth Planning Services first reported a position in RNAM in Q4 2025 and held it in 1 quarter. The position peaked at $21.4K in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.
- Pinnacle Wealth Planning Services reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
- Pinnacle Wealth Planning Services sold 297 Avidity Biosciences shares in Q1 2026, an estimated $21.4K.
- Pinnacle Wealth Planning Services first reported a position in Avidity Biosciences in Q4 2025 and held it in 1 quarter.
- Pinnacle Wealth Planning Services's Avidity Biosciences position peaked at $21.4K in Q4 2025.
- 1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.
Based on Pinnacle Wealth Planning Services's 13F filing for Q1 2026, filed 11 May 2026.